NCT01655836View on ClinicalTrials.gov

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 4, 2012

Primary Completion Date

July 27, 2016

Study Completion Date

January 1, 2040

Conditions
Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer
Interventions
RADIATION

Brachytherapy

Undergo high dose rate brachytherapy

RADIATION

Stereotactic Body Radiation Therapy

Undergo stereotactic body radiation therapy

PROCEDURE

Quality-of-life assessment

Ancillary studies

OTHER

Questionnaire administration

Ancillary studies

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT01655836 - High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter